
Low 5-ARI Use Linked to Increased Suicide Risk, Reduced Heart Disease Mortality
Low cumulative 5α-reductase inhibitors (5-ARIs) doses in individuals with benign prostatic hyperplasia (BPH) or androgenic alopecia are linked to an increased suicide risk and a diminished risk of cardiovascular mortality, new findings suggest, …